University Of Cologne
Clinical trials sponsored by University Of Cologne, explained in plain language.
-
New strategy aims to stop Cancer's return after transplant
Disease control CompletedThis study tested whether giving a drug called brentuximab vedotin for up to one year after a stem cell transplant could help prevent Hodgkin lymphoma from coming back. The treatment was given to 14 adults whose cancer had returned or hadn't responded to previous treatments. Rese…
Phase: PHASE2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists track COVID's hidden toll on kidneys
Knowledge-focused CompletedThis study created a registry to understand how COVID-19 affects the kidneys. It tracked 500 patients with confirmed COVID-19 to see how often kidney injury occurred, who was most at risk, and what the outcomes were. The goal was to gather information to help guide future treatme…
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Study warns of hidden dangers in blood disorder treatment
Knowledge-focused CompletedThis study looked back at 223 adults with a rare, serious blood clotting disorder (aTTP) who were treated with the drug caplacizumab. Researchers analyzed how patients' platelet counts changed after starting the drug to identify common patterns and potential pitfalls. The goal is…
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Heart monitor clues for dangerous salt imbalance
Knowledge-focused CompletedThis study looked back at medical records to understand how very low sodium levels affect the heart's electrical activity. Researchers analyzed ECG readings from 250 emergency room patients before and after their low sodium was treated. The goal was to see if specific ECG pattern…
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC